Relmada Therapeutics (RLMD) Net Equity Issued and Repurchased (2012 - 2026)
Relmada Therapeutics (RLMD) recorded Net Equity Issued and Repurchased of $160 million in Q1 2026.
Powered by 
Analysis
Relmada Therapeutics (RLMD) Net Equity Issued and Repurchased (2012 - 2026) Analysis & Trends
For FY2025, Relmada Therapeutics reported Net Equity Issued and Repurchased of $93.64 million.
- Annual Net Equity Issued and Repurchased has a five-year compound annual growth rate of 36.5% (FY2020 to FY2025).
- Across earlier years, Net Equity Issued and Repurchased came in at $246,747 in FY2024, $42.73 million in FY2022 (-76.9%) and $184.64 million in FY2021 (+832.9%).
- The Q1 2026 figure is the highest quarterly Net Equity Issued and Repurchased since Q4 2021.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Net Equity Issued (Qtr) |
|---|---|---|---|---|---|
| 1 | Johnson & Johnson | 638.12 Bn | 556.64 Bn | 17.26 Bn | - |
| 2 | AbbVie | 462.60 Bn | 435.75 Bn | 12.70 Bn | - |
| 3 | Merck | 358.70 Bn | 313.13 Bn | 12.21 Bn | 43.00 Mn |
| 4 | Novartis Ag | 272.16 Bn | 228.03 Bn | 11.24 Bn | - |
| 5 | Astrazeneca | 250.36 Bn | 223.92 Bn | 12.86 Bn | 6.00 Mn |
| 6 | Amgen | 227.87 Bn | 183.27 Bn | 7.24 Bn | - |
| 7 | Gilead Sciences | 184.97 Bn | 159.08 Bn | 6.22 Bn | 9.00 Mn |
| 8 | Pfizer | 162.61 Bn | 109.56 Bn | 10.94 Bn | - |
| 9 | Vertex Pharmaceuticals | 132.45 Bn | 104.46 Bn | 2.84 Bn | 47.70 Mn |
| 10 | Relmada Therapeutics | 402.15 Mn | 402.15 Mn | - | - |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Mar 31, 2026 | 160.00 Mn |
| Mar 31, 2024 | 246,747.00 |
| Jun 30, 2022 | 13.15 Mn |
| Mar 31, 2022 | 29.58 Mn |
| Dec 31, 2021 | 161.23 Mn |
| Sep 30, 2021 | -42,014.00 |
| Jun 30, 2021 | 22.00 Mn |
| Mar 31, 2021 | 1.46 Mn |
| Dec 31, 2020 | -24,953.00 |
| Sep 30, 2020 | -38,421.00 |
| Jun 30, 2020 | 16.81 Mn |
| Mar 31, 2020 | 3.04 Mn |
| Sep 30, 2019 | 825,749.00 |
| Jun 30, 2019 | 10.86 Mn |
| Mar 31, 2019 | 1.73 Mn |
| Dec 31, 2018 | 4.35 Mn |
| Sep 30, 2018 | 404,500.00 |
| Jun 30, 2015 | -19,201.00 |
| Sep 30, 2014 | 4.31 Mn |
| May 31, 2012 | 9,500.00 |
API Access
Relmada Therapeutics Net Equity Issued and Repurchased API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=net-equity-issued-and-repurchased&ticker=RLMD&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "net-equity-issued-and-repurchased", "ticker": "RLMD", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=net-equity-issued-and-repurchased&ticker=RLMD&period=max&api_key=YOUR_API_KEY");
const data = await res.json();